Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
By Sriparna Roy (Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on…
By Sriparna Roy (Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on…
WASHINGTON (Reuters) – U.S. President Joe Biden vowed to stay in the presidential race on Monday, saying he is confident…
By Sabrina Valle and Tanay Dhumal HOUSTON (Reuters) – Exxon Mobil Corp on Monday signaled that lower refining margins across…
MANILA (Reuters) – The Philippine Coast Guard (PCG) said on Saturday that China’s largest coastguard vessel has anchored in Manila’s…
WASHINGTON (Reuters) – Eighty-six percent of Democrats said they would vote for U.S. President Joe Biden in a match up…
By Samia Nakhoul, Muhammad Al Gebaly and Nidal al-Mughrabi DUBAI/CAIRO (Reuters) -Hamas has accepted a U.S. proposal to begin talks…
BANGKOK (Reuters) – China’s BYD will acquire a 20% stake in its local distributor Rever Automotive in Thailand, its largest…
By Nell Mackenzie LONDON (Reuters) – A win for Donald Trump in the U.S. presidential election in November would herald…
SHANGHAI (Reuters) – Chinese tech companies, from industry giants to ambitious startups, converged at the World AI Conference in Shanghai…
By Jonathan Stempel NEW YORK (Reuters) – A U.S. judge threw out a central claim in a Federal Trade Commission…